Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Ischemia reperfusion injury (IRI) is an adverse factor for hepatocellular carcinoma (HCC) recurrence after liver transplantation. Ischemic-free liver transplantation (IFLT) is a novel transplant procedure that can largely reduce or even prevent IRI, but the clinical relevance of IFLT and the recurre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yunhua, Wang, Tielong, Ju, Weiqiang, Li, Fangcong, Zhang, Qi, Chen, Zhitao, Gong, Jinlong, Zhao, Qiang, Wang, Dongping, Chen, Maogen, Guo, Zhiyong, He, Xiaoshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711268/
https://www.ncbi.nlm.nih.gov/pubmed/34966679
http://dx.doi.org/10.3389/fonc.2021.773535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711268/
https://www.ncbi.nlm.nih.gov/pubmed/34966679
http://dx.doi.org/10.3389/fonc.2021.773535

Ejemplares similares